脑梗死急性期他汀用药剂量与康复预后相关性的回顾研究

被引:7
作者
谈晓牧 [1 ]
曾艳芳 [1 ]
刘建国 [2 ]
刘怀翔 [3 ]
耿晓坤 [1 ]
孟繁花 [1 ]
张伟东 [1 ]
魏建朝 [1 ]
杜会山 [1 ]
机构
[1] 首都医科大学附属北京潞河医院神经内科
[2] 海军总医院神经内科
[3] 天津医科大学第二附属医院神经内科
关键词
脑梗死; 他汀; 康复; 预后;
D O I
10.15932/j.0253-9713.2016.5.012
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
目的探讨脑梗死急性期口服不同剂量阿托伐他汀对患者临床康复预后的影响。方法回顾性分析356例脑梗死患者的临床资料,根据患者住院期间口服阿托伐他汀剂量进行分组,20 mg组153例,40 mg组137例,60 mg组19例,80 mg组47例,比较分析各组患者的人口学资料、脑血管病危险因素分布及主要危险因素控制用药种类分布和NIHSS评分。结果各组患者人口学资料、脑血管病危险因素分布和主要危险因素控制用药种类分布差异无统计学意义。组间NIHSS评分有效率差异有统计学意义(χ2=8.041,P=0.045),应用卡方分割法进一步检验,显示20~40 mg组与60~80 mg组NIHSS评分有效率差异具有显著性(有效率分别为32.76%、50.00%,χ2=6.941,P=0.008)。Logistic回归分析显示阿托伐他汀剂量为急性脑梗死临床康复预后的独立影响因素,OR值为1.382,95%可信区间1.111~1.719,P=0.004。结论脑梗死急性期应用高剂量阿托伐他汀对于改善患者康复预后具有更好的促进作用。
引用
收藏
页码:424 / 428
页数:5
相关论文
共 12 条
[1]   应用超声评估阿托伐他汀对颈动脉粥样硬化性狭窄病变的影响 [J].
华扬 ;
焦志欣 ;
贾凌云 ;
段春 ;
凌晨 .
中国脑血管病杂志, 2013, (11) :583-587
[2]   Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke [J].
Tziomalos, Konstantinos ;
Giampatzis, Vasilios ;
Bouziana, Stella D. ;
Spanou, Marianna ;
Kostaki, Stavroula ;
Papadopoulou, Maria ;
Angelopoulou, Stella-Maria ;
Konstantara, Filitsa ;
Savopoulos, Christos ;
Hatzitolios, Apostolos I. .
ATHEROSCLEROSIS, 2015, 243 (01) :65-70
[3]   Statin treatment is associated with improved prognosis in patients with AF-related stroke [J].
Ntaios, G. ;
Papavasileiou, V. ;
Makaritsis, K. ;
Milionis, H. ;
Manios, E. ;
Michel, P. ;
Lip, G. Y. H. ;
Vemmos, K. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) :129-133
[4]  
High-Dose Rosuvastatin Treatment for Multifocal Stroke in Trauma-Induced Cerebral Fat Embolism Syndrome: A Case Report[J] . Lesta D. Whalen,Sandeep P. Khot,Stephen W. Standage.Pediatric Neurology . 2014
[5]  
The Effect of Body Mass Index on Stroke Rehabilitation[J] . David T. Burke,Samir Al-Adawi,Regina B. Bell,Kirk Easley,Shou Chen,Daniel P. Burke.Archives of Physical Medicine and Rehabilitation . 2014
[6]   Relationship Between Body Mass Index and Rehabilitation Outcomes in Chronic Stroke [J].
Sheffler, Lynne R. ;
Knutson, Jayme S. ;
Gunzler, Douglas ;
Chae, John .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2012, 91 (11) :951-956
[7]  
The association of statin therapy and high-sensitivity C‐reactive protein level for predicting clinical outcome in acute non-cardioembolic ischemic stroke[J] . Nai-Wen Tsai,Lian-Hui Lee,Chi-Ren Huang,Wen-Neng Chang,Shang-Der Chen,Hung-Chen Wang,Yu-Jun Lin,Wei-Che Lin,Yi-Fang Chiang,Tsu-Kung Lin,Ben-Chung Cheng,Yu-Jih Su,Chia-Te Kung,Shu-Hua Hung,Hsueh-Wen Chang,Cheng-Hsien Lu.Clinica Chimica Acta . 2012 (23-2)
[8]  
Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats[J] . Giuseppina Mariucci,Elena Taha,Michela Tantucci,Cristiano Spaccatini,Alessandro Tozzi,Maria Vittoria Ambrosini.European Journal of Pharmacology . 2011 (2)
[9]  
Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats[J] . Harikesh Kalonia,Puneet Kumar,Anil Kumar.Behavioural Brain Research . 2010 (1)
[10]  
Effects of age, gender, and cognitive, functional and motor statuson functional outcomes of stroke rehabilitation[J] . Kadr&idot,ye &Ouml,ne&scedil,EbruYilmaz Yal&ccedil,inkaya,Banu &Ccedil,et&idot,nkaya Toklu,Nil &Ccedil,a&gbreve,lar.Neurorehabilitation . 2009 (4)